These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34677661)

  • 1. Comparison between different prognostic models to be used for metastatic bone disease on appendicular skeleton in a Chilean population.
    Alfaro PA; Delgado J; Dumas A; Mesa C; Wevar O; Herrera C; Padilla F; Botello E
    Eur J Orthop Surg Traumatol; 2021 Dec; 31(8):1657-1662. PubMed ID: 34677661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of survival after surgical management of femoral metastatic bone disease - A comparison of prognostic models.
    Meares C; Badran A; Dewar D
    J Bone Oncol; 2019 Apr; 15():100225. PubMed ID: 30847272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can A Multivariate Model for Survival Estimation in Skeletal Metastases (PATHFx) Be Externally Validated Using Japanese Patients?
    Ogura K; Gokita T; Shinoda Y; Kawano H; Takagi T; Ae K; Kawai A; Wedin R; Forsberg JA
    Clin Orthop Relat Res; 2017 Sep; 475(9):2263-2270. PubMed ID: 28560532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. External Validation of PATHFx Version 3.0 in Patients Treated Surgically and Nonsurgically for Symptomatic Skeletal Metastases.
    Anderson AB; Wedin R; Fabbri N; Boland P; Healey J; Forsberg JA
    Clin Orthop Relat Res; 2020 Apr; 478(4):808-818. PubMed ID: 32195761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting survival for metastatic spine disease: a comparison of nine scoring systems.
    Ahmed AK; Goodwin CR; Heravi A; Kim R; Abu-Bonsrah N; Sankey E; Kerekes D; De la Garza Ramos R; Schwab J; Sciubba DM
    Spine J; 2018 Oct; 18(10):1804-1814. PubMed ID: 29567516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-reactive protein and tumour diagnosis predict survival in patients treated surgically for long bone metastases.
    Errani C; Cosentino M; Ciani G; Ferra L; Alfaro PA; Bordini B; Donati DM
    Int Orthop; 2021 May; 45(5):1337-1346. PubMed ID: 33392682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2015 Marshall Urist Young Investigator Award: Prognostication in Patients With Long Bone Metastases: Does a Boosting Algorithm Improve Survival Estimates?
    Janssen SJ; van der Heijden AS; van Dijke M; Ready JE; Raskin KA; Ferrone ML; Hornicek FJ; Schwab JH
    Clin Orthop Relat Res; 2015 Oct; 473(10):3112-21. PubMed ID: 26155769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. External Validation and Optimization of the SPRING Model for Prediction of Survival After Surgical Treatment of Bone Metastases of the Extremities.
    Sørensen MS; Gerds TA; Hindsø K; Petersen MM
    Clin Orthop Relat Res; 2018 Aug; 476(8):1591-1599. PubMed ID: 30020148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Prediction of Survival after Surgical Management of Bone Metastases of the Extremities-A Comparison of Prognostic Models.
    Ben Gal O; Soh TCF; Vaughan S; Jayasanker V; Mahendra A; Gupta S
    Curr Oncol; 2022 Jul; 29(7):4703-4716. PubMed ID: 35877233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can a Bayesian belief network for survival prediction in patients with extremity metastases (PATHFx) be externally validated in an Asian cohort of 356 surgically treated patients?
    Hsieh HC; Lai YH; Lee CC; Yen HK; Tseng TE; Yang JJ; Ling SY; Hu MH; Hou CH; Yang RS; Wedin R; Forsberg JA; Lin WH
    Acta Orthop; 2022 Sep; 93():721-731. PubMed ID: 36083697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of survival prediction models for bone metastases of the extremities following surgery.
    Park JH; Won J; Kim HS; Kim Y; Kim S; Han I
    Bone Joint J; 2024 Feb; 106-B(2):203-211. PubMed ID: 38295850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of survival after surgery due to skeletal metastases in the extremities.
    Sørensen MS; Gerds TA; Hindsø K; Petersen MM
    Bone Joint J; 2016 Feb; 98-B(2):271-7. PubMed ID: 26850435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can We Estimate Short- and Intermediate-term Survival in Patients Undergoing Surgery for Metastatic Bone Disease?
    Forsberg JA; Wedin R; Boland PJ; Healey JH
    Clin Orthop Relat Res; 2017 Apr; 475(4):1252-1261. PubMed ID: 27909972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of post-radiotherapy survival for bone metastases: a comparison of the 3-variable number of risk factors model with the new Katagiri scoring system.
    Sakurai T; Takamatsu S; Shimoyachi N; Shibata S; Makino M; Ohashi S; Taima Y; Minamikawa R; Kumano T; Gabata T
    J Radiat Res; 2022 Mar; 63(2):303-311. PubMed ID: 34977925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting the survival of patients with bone metastases treated with radiation therapy: a validation study of the Katagiri scoring system.
    Kubota H; Soejima T; Sulaiman NS; Sekii S; Matsumoto Y; Ota Y; Tsujino K; Fujita I; Fujimoto T; Morishita M; Ikegaki J; Matsumoto K; Sasaki R
    Radiat Oncol; 2019 Jan; 14(1):13. PubMed ID: 30658673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting survival of patients with spinal metastatic disease using PathFx 3.0 - A validation study of 668 patients in Sweden.
    Carrwik C; Tsagkozis P; Wedin R; Robinson Y
    Brain Spine; 2022; 2():101669. PubMed ID: 36506283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Glasgow Prognostic Score predicts poor survival in cisplatin-based treated patients with metastatic nasopharyngeal carcinoma.
    Chen C; Sun P; Dai QS; Weng HW; Li HP; Ye S
    PLoS One; 2014; 9(11):e112581. PubMed ID: 25393117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of seven prognostic scores in patients with surgically treated epidural metastatic spine disease.
    Westermann L; Olivier AC; Samel C; Eysel P; Herren C; Sircar K; Zarghooni K
    Acta Neurochir (Wien); 2020 Jan; 162(1):109-119. PubMed ID: 31781995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival Prognostication in Patients with Skeletal Metastases from Nasopharyngeal Carcinoma: An Evaluation of the Scandinavian Sarcoma Group, Katagiri and Bauer Scoring Systems.
    Tan JJ; Zaw AS; Malhotra R; Wai KL; Tan JY; Kumar N
    Ann Acad Med Singap; 2016 Feb; 45(2):51-60. PubMed ID: 27125346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. External validation of the PATHFx decision-support tool on Turkish patients with skeletal metastasis.
    Ozkan K; Ozturan B; Karadag Z; Erol B; Alpan B; Ozger H; Gurkan V; Sofulu O; Yalcinkaya M; Okay E; Forsberg JA
    Indian J Cancer; 2023 Feb; ():. PubMed ID: 36861722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.